Casa asdas

Subgroups according to BASDAI/ASDAS category (baseline)

Por um escritor misterioso

Last updated 16 novembro 2024

Subgroups according to BASDAI/ASDAS category (baseline)

Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis

Comparison of (A) ASDAS vs SASDAS in their capacity to each

Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials

Standardized ASDAS vs standardized SASDAS for (A) baseline pooled data

Biologics Targeting, Ankylosing Spondylitis

Change from baseline in BASFI, BASDAI, BASMI linear and ASDAS, and

Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials

Biologics Targeting, Ankylosing Spondylitis

Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

Extended Report Semantic Scholar

Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies

The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology

Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5

A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis, Arthritis Research & Therapy

Recomendado para você